| Year |
Citation |
Score |
| 2024 |
Supti ST, Koehn LM, Newman SA, Pan Y, Nicolazzo JA. Iron Reduces the Trafficking of Fatty Acids from Human Immortalised Brain Microvascular Endothelial Cells Through Modulation of Fatty Acid Transport Protein 1 (FATP1/SLC27A1). Pharmaceutical Research. PMID 39044044 DOI: 10.1007/s11095-024-03743-w |
0.394 |
|
| 2023 |
Pyun J, Koay H, Runwal P, Mawal C, Bush AI, Pan Y, Donnelly PS, Short JL, Nicolazzo JA. Cu(ATSM) Increases P-Glycoprotein Expression and Function at the Blood-Brain Barrier in C57BL6/J Mice. Pharmaceutics. 15. PMID 37631298 DOI: 10.3390/pharmaceutics15082084 |
0.342 |
|
| 2022 |
Pan Y, Kagawa Y, Sun J, Turner BJ, Huang C, Shah AD, Schittenhelm RB, Nicolazzo JA. Altered Blood-Brain Barrier Dynamics in the C9orf72 Hexanucleotide Repeat Expansion Mouse Model of Amyotrophic Lateral Sclerosis. Pharmaceutics. 14. PMID 36559296 DOI: 10.3390/pharmaceutics14122803 |
0.359 |
|
| 2021 |
Newman SA, Pan Y, Short JL, Nicolazzo JA. Increasing Intracellular Levels of Iron with Ferric Ammonium Citrate Leads to Reduced P-glycoprotein Expression in Human Immortalised Brain Microvascular Endothelial Cells. Pharmaceutical Research. PMID 33532991 DOI: 10.1007/s11095-021-03006-y |
0.355 |
|
| 2020 |
Jin L, Pan Y, Tran NLL, Polychronopoulos LN, Warrier A, Brouwer KLR, Nicolazzo JA. Intestinal permeability and oral absorption of selected drugs are reduced in a mouse model of familial Alzheimer's disease. Molecular Pharmaceutics. PMID 32212738 DOI: 10.1021/Acs.Molpharmaceut.9B01227 |
0.417 |
|
| 2020 |
Low YL, Jin L, Morris ER, Pan Y, Nicolazzo JA. Pioglitazone increases blood-brain barrier expression of fatty acid-binding protein 5 and docosahexaenoic acid trafficking into the brain. Molecular Pharmaceutics. PMID 31944767 DOI: 10.1021/Acs.Molpharmaceut.9B01131 |
0.5 |
|
| 2019 |
Pan Y, Omori K, Ali I, Tachikawa M, Terasaki T, Brouwer KLR, Nicolazzo JA. Increased expression of renal drug transporters in a mouse model of familial Alzheimer's disease. Journal of Pharmaceutical Sciences. PMID 30825461 DOI: 10.1016/J.Xphs.2019.02.016 |
0.413 |
|
| 2019 |
McInerney MP, Pan Y, Volitakis I, Bush AI, Short JL, Nicolazzo JA. The effects of clioquinol on P-glycoprotein expression and biometal distribution in the mouse brain microvasculature. Journal of Pharmaceutical Sciences. PMID 30738852 DOI: 10.1016/J.Xphs.2019.01.030 |
0.428 |
|
| 2018 |
Pan Y, Omori K, Ali I, Tachikawa M, Terasaki T, Brouwer KLR, Nicolazzo JA. Altered expression of small intestinal drug transporters and hepatic metabolic enzymes in a mouse model of familial Alzheimer's disease. Molecular Pharmaceutics. PMID 30074800 DOI: 10.1021/Acs.Molpharmaceut.8B00500 |
0.425 |
|
| 2018 |
Pan Y, Nicolazzo JA. Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics. Advanced Drug Delivery Reviews. PMID 29665383 DOI: 10.1016/J.Addr.2018.04.009 |
0.343 |
|
| 2018 |
Pan Y, Morris ER, Scanlon MJ, Marriott PJ, Porter CJ, Nicolazzo JA. Dietary Docosahexaenoic Acid Supplementation Enhances Expression of Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier and Brain Docosahexaenoic Acid Levels. Journal of Neurochemistry. PMID 29582413 DOI: 10.1111/Jnc.14342 |
0.491 |
|
| 2018 |
Pan Y, Short JL, Newman SA, Choy KHC, Tiwari D, Yap C, Senyschyn D, Banks WA, Nicolazzo JA. Cognitive benefits of lithium chloride in APP/PS1 mice are associated with enhanced brain clearance of β-amyloid. Brain, Behavior, and Immunity. PMID 29545118 DOI: 10.1016/J.Bbi.2018.03.007 |
0.442 |
|
| 2017 |
Lee GS, Pan Y, Scanlon MJ, Porter CJH, Nicolazzo JA. Fatty acid binding protein 5 mediates the uptake of fatty acids, but not drugs, into human brain endothelial cells. Journal of Pharmaceutical Sciences. PMID 29247738 DOI: 10.1016/J.Xphs.2017.11.024 |
0.451 |
|
| 2017 |
Pan Y, Choy KHC, Marriott PJ, Chai SY, Scanlon MJ, Porter CJH, Short JL, Nicolazzo JA. Reduced Blood-Brain Barrier Expression of Fatty-Acid Binding Protein 5 is associated with Increased Vulnerability of APP/PS1 mice to Cognitive Deficits from Low Omega-3 Fatty Acid Diets. Journal of Neurochemistry. PMID 29105065 DOI: 10.1111/Jnc.14249 |
0.482 |
|
| 2017 |
Newman SA, Pan Y, Short JL, Nicolazzo JA. Assessing the impact of lithium chloride on the expression of P-glycoprotein at the blood-brain barrier. Journal of Pharmaceutical Sciences. PMID 28093288 DOI: 10.1016/J.Xphs.2017.01.013 |
0.422 |
|
| 2017 |
McInerney MP, Pan Y, Short JL, Nicolazzo JA. Development and validation of an in-cell western for quantifying P-glycoprotein expression in human brain microvascular endothelial (hCMEC/D3) cells. Journal of Pharmaceutical Sciences. PMID 28065764 DOI: 10.1016/J.Xphs.2016.12.017 |
0.309 |
|
| 2016 |
Pan Y, Short JL, Choy KH, Zeng AX, Marriott PJ, Owada Y, Scanlon MJ, Porter CJ, Nicolazzo JA. Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 11755-11767. PMID 27852782 DOI: 10.1523/Jneurosci.1583-16.2016 |
0.44 |
|
| 2015 |
Pan Y, Scanlon MJ, Owada Y, Yamamoto Y, Porter CJ, Nicolazzo JA. Fatty acid-binding protein 5 facilitates the blood-brain barrier transport of docosahexaenoic acid. Molecular Pharmaceutics. PMID 26455443 DOI: 10.1021/Acs.Molpharmaceut.5B00580 |
0.438 |
|
| 2015 |
Pan Y, Khalil H, Nicolazzo JA. The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier? Current Clinical Pharmacology. 10: 222-41. PMID 26338174 DOI: 10.2174/157488471003150820151532 |
0.435 |
|
| 2014 |
Caon T, Pan Y, Simões CM, Nicolazzo JA. Exploiting the buccal mucosa as an alternative route for the delivery of donepezil hydrochloride. Journal of Pharmaceutical Sciences. 103: 1643-51. PMID 24687969 DOI: 10.1002/Jps.23950 |
0.307 |
|
| Show low-probability matches. |